{"name": "Everist Genomics",
 "permalink": "everist-genomics",
 "crunchbase_url": "http://www.crunchbase.com/company/everist-genomics",
 "homepage_url": "http://www.everistgenomics.com/",
 "blog_url": "http://blog.everistgenomics.com/",
 "blog_feed_url": "",
 "twitter_username": "EveristGenomic",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "personalized-medicine-company, unique-diagnostics, prognostics, therapeutic-selection-technologies, egi",
 "alias_list": null,
 "email_address": "fau@everistgenomics.com",
 "phone_number": "00 1 855-383-7478",
 "description": "Personalized medicine company",
 "created_at": "Mon Jun 04 12:35:54 UTC 2012",
 "updated_at": "Sat Jun 09 16:28:24 UTC 2012",
 "overview": "\u003Cp\u003EEverist Genomics, Inc. (EGI) is a personalized medicine company, which develops and commercializes medically unique diagnostics, prognostics and therapeutic selection technologies. EGI is focused on rapidly growing disease areas with major unmet needs, including cancer, cardiovascular disease and metabolic disease (e.g. diabetes). EGI\u2019s innovative products successfully integrate with mobile digital services, smartphones and tablet computers resulting in advanced medical technology, which until now has been confined to the hospital setting.\u003C/p\u003E\n\n\u003Cp\u003EMission\nEverist Genomics is driving growth by developing innovative prognostics with potential for substantive impact on medical and financial outcomes. Our strategy centers on proprietary research and development, targeted acquisitions, and in-licensing. Everist Genomics is currently developing a range of products aimed at improving treatment outcomes in:\u003C/p\u003E\n\n\u003Cp\u003E\u2022 Cancer and Cancer Supportive Care\u003C/p\u003E\n\n\u003Cp\u003E\u2022 Cardiovascular Disease\u003C/p\u003E\n\n\u003Cp\u003E\u2022 Metabolic Disease (e.g. diabetes)\u003C/p\u003E\n\n\u003Cp\u003E\u2022 Neurodegenerative Diseases (e.g. Alzheimer\u2019s and Parkinson\u2019s disease)\nDescription\nEverist Genomics\u2019 mission is developing and commercializing molecular assays and sensor technology aimed at improving patient outcomes and cost-efficiency through better-informed clinical decisions.\u003C/p\u003E\n\n\u003Cp\u003EAt the core of our success is our evolutionary and proprietary (patent-protected) Evolver technology platform, which accelerates the development of innovative molecular prognostic tests. Utilizing the Evolver technology, Everist Genomics has succeeded in developing a breakthrough colorectal cancer prognostic test (OncoDefender\u2122-CRC), intended to help guide treatment decisions following surgery for Stage I/II colon cancer and Stage I rectal cancer.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       40],
      "assets/images/resized/0019/3786/193786v2-max-150x150.png"],
     [[250,
       66],
      "assets/images/resized/0019/3786/193786v2-max-250x250.png"],
     [[299,
       80],
      "assets/images/resized/0019/3786/193786v2-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Ph.D. Chief Executive Officer",
    "person":
     {"first_name": "Prasad",
      "last_name": "Sunkara",
      "permalink": "prasad-sunkara",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "Head Office",
    "address1": "709 W. Ellsworth Road",
    "address2": "",
    "zip_code": "48108",
    "city": "Ann Arbor",
    "state_code": "MI",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        99],
       "assets/images/resized/0019/3783/193783v2-max-150x150.jpg"],
      [[250,
        166],
       "assets/images/resized/0019/3783/193783v2-max-250x250.jpg"],
      [[450,
        299],
       "assets/images/resized/0019/3783/193783v2-max-450x450.jpg"]],
    "attribution": null},
   {"available_sizes":
     [[[99,
        150],
       "assets/images/resized/0019/3784/193784v2-max-150x150.jpg"],
      [[166,
        250],
       "assets/images/resized/0019/3784/193784v2-max-250x250.jpg"],
      [[299,
        450],
       "assets/images/resized/0019/3784/193784v2-max-450x450.jpg"]],
    "attribution": null},
   {"available_sizes":
     [[[150,
        99],
       "assets/images/resized/0019/3785/193785v2-max-150x150.jpg"],
      [[250,
        166],
       "assets/images/resized/0019/3785/193785v2-max-250x250.jpg"],
      [[450,
        299],
       "assets/images/resized/0019/3785/193785v2-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}